Goal Directed Hemodynamic Management and Renal Outcome After Major Non-cardiac Surgery
NCT ID: NCT01035541
Last Updated: 2013-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
180 participants
OBSERVATIONAL
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PGDT in Patients Undergoing Kidney Transplant
NCT05035537
Hypotension Prediction With HPI Algorithm During Major Gynecologic Oncologic Surgery
NCT04547491
The Effect of Perioperative Cardiac Output-guided GDT on Oxygen Delivery, Consumption, and Microcirculatory Perfusion
NCT05090254
Perioperative Goal Directed Therapy in Kidney Transplantation
NCT03776396
Goal-directed Hemodynamic Therapy in Patiens Undergoing Major Hepatic Resection
NCT04517409
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Until now just a few studies are published on prevention or therapy of AKI after major surgery. Most of these investigations are underpowered or show just marginal benefit. There are no studies published investigating the impact of goal-directed hemodynamic management on renal outcome following non-cardiac major surgery, even though hemodynamic stability seems to be of paramount importance for the kidneys.
Aim of this study is to investigate the impact of a goal directed hemodynamic management on renal outcome after major non-cardiac surgery.
Therefore patients will be randomized in one of two groups, the PiCCO group with goal directed hemodynamic management and the Control group, where PICCO data will be collected but will not influence hemodynamic management. In both groups the monitoring with transpulmonary thermodilution will be continued in the intensive care unit until 72 hours after surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
P group
Fluid Management according to measurements with PiCCO®
PiCCO® Monitoring
Fluid and vasopressor management according to PiCCO measruements
C group
Conventional fluid management
PiCCO® Monitoring
Fluid and vasopressor management according to PiCCO measruements
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PiCCO® Monitoring
Fluid and vasopressor management according to PiCCO measruements
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* gastrectomy
* pancreas surgery
* small bowel surgery
* esophageal surgery
* Age ≥ 18 years
* ASA classification I to III
* Written informed consent
Exclusion Criteria
* Contraindications for an arterial line in the femoral artery:
* stents
* bypasses
* severe peripheral artery occlusive disease
* ASA classification IV to V
* Pregnant Woman
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technical University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bettina Jungwirth, MD
Role: PRINCIPAL_INVESTIGATOR
Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München
Munich, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Goepfert MS, Reuter DA, Akyol D, Lamm P, Kilger E, Goetz AE. Goal-directed fluid management reduces vasopressor and catecholamine use in cardiac surgery patients. Intensive Care Med. 2007 Jan;33(1):96-103. doi: 10.1007/s00134-006-0404-2. Epub 2006 Nov 21.
Schmid S, Kapfer B, Heim M, Bogdanski R, Anetsberger A, Blobner M, Jungwirth B. Algorithm-guided goal-directed haemodynamic therapy does not improve renal function after major abdominal surgery compared to good standard clinical care: a prospective randomised trial. Crit Care. 2016 Mar 8;20:50. doi: 10.1186/s13054-016-1237-1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IROM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.